Login / Signup

Brief intervention for chronic liver disease patients with alcohol use disorder in a hepatology outpatient unit: Effects and limitations.

Nagisa HaraAtsushi HiraokaMasato NakaiMakoto ShirakiTadashi NamisakiHisamitsu MiyaakiTakuro HisanagaHirokazu TakahashiHideko OhamaFujimasa TadaNaoya SakamotoKazuhiko NakaoTaro TakamiYuichiro EguchiHitoshi Yoshiji
Published in: Hepatology research : the official journal of the Japan Society of Hepatology (2024)
Patients with an alcohol use disorder as well as those with alcohol dependency who received BI showed a significant decline in AUDIT score, although the score of the follow-up AUDIT indicated continued alcohol use disorder. In addition to BI, medication with nalmefene should be considered, based on individual factors.
Keyphrases
  • alcohol use disorder
  • randomized controlled trial
  • healthcare
  • adverse drug
  • emergency department
  • drug induced